Open Systems Pharmacology
ForumSetup
v11
v11
  • README
  • Open Systems Pharmacology Suite Manual & Copyright
  • How to Contribute
  • Mechanistic Modeling of Pharmacokinetics and Dynamics
    • Modeling Concepts
      • PBPK Modeling - Systems Biology
      • PK and PD Modeling
      • Principles of PBPK Modeling
      • Expression Data for PBPK Modeling
      • Modeling of Proteins
      • PD and Reaction Network Modeling
  • Open Systems Pharmacology Suite
    • Modules, Philosophy, and Building Blocks
    • Getting Started
  • Working with PK-Sim
    • PK-Sim Documentation
      • Quick Guide‌
      • Options
      • Projects
      • Creating Individuals
      • Creating Populations
      • Expression Profile
      • Compounds: Definition and Work Flows
      • Compounds: Defining Inhibition/Induction Processes
      • Administration Protocols
      • Events
      • Formulations
      • Simulations
      • Importing and Exporting Project Data and Models
      • Conversion of Projects from Previous Version
      • Command Line Interface - CLI
  • Working with MoBi
    • MoBi‌ Documentation
      • First Steps
      • The Building Block Concept
      • Model Building and Model Components
      • Setting up a Simulation
      • Simulation Results
      • Diagrams Overview
      • Tools
      • Reuse of Project Information from Previous Versions
  • Shared Tools and Example Workflows
    • Features of Tables
    • Chart Component
    • Comparison of Building Blocks
    • Parameter Identification
    • Sensitivity Analysis
    • Import and Edit of Observed Data
    • Default, Display and Base Units
    • Working Journal
    • History Manager and History Reporting‌
    • Setting up a Reaction Network‌
    • Setting up a Drug-Drug Interaction in PK-Sim‌
    • Qualification‌
  • Working with R‌
    • ospsuite-R Documentation
  • Appendix
    • Appendix
    • OSP Suite Fact Sheet
  • References
    • References
Powered by GitBook
On this page
  1. Mechanistic Modeling of Pharmacokinetics and Dynamics
  2. Modeling Concepts

Expression Data for PBPK Modeling

PreviousPrinciples of PBPK ModelingNextModeling of Proteins

Last updated 3 years ago

​ The most prominent examples of proteins that affect PK are enzymes that catalyze the metabolization of drugs or transporters that can heavily influence drug absorption or distribution. Proteins can also include those which a drug binds to, either by design (drug-target interaction) or as an off- target interaction or side-effect. Such binding can also influence distribution as well as metabolization and excretion of the drug.

​ In physiologically-based PK modeling approaches, it is desirable to mechanistically reflect such relevant drug-protein interactions. In some cases, the addition of one specific protein into the most relevant organ is sufficient to describe a process, e.g. cytochrome P450 3A4-mediated metabolization in the liver. In other cases it may be necessary to consider protein levels in more than one organ. The integration of a protein expression database with PK-Sim makes it easy to assign parameter values for the involved proteins to account for differential protein expression in various organs and assign them to virtual individuals. As such, the user describes the absolute amount of protein in one reference organ and through the use of relative expressions as generated with the protein database, the protein concentrations are fixed for all organs where the protein is present. Details on how to use the protein expression database are described in . See [] for an example that demonstrates how taking into account protein expression leads to an increase in PBPK model quality. Alternatively, the user can assign one set of kinetic parameters characterizing the drug-protein interaction (e.g. kcat and Km, or kon and koff) and use this in all organs.

PK-Sim® - Expression Data
46